Spanish Red Biotech Pipeline

Oryzon

Iadademstat (ORY-1001) - Selective LSD1 inhibitor

Type: Biodrugs/ Drugs
Therapeutic area:
Indication: NETs R/R Clinical Trial "NET Basket" (Combo w other agents) In preparation IND 1H22 / FPI 2H22
Phase: 2Phase II, 1Phase I, 2Regulatory Preclinical, 1Non Regulatory Preclinical